Mod­er­na CEO Ban­cel hits the gas with vari­ant-spe­cif­ic boost­ers and a very ear­ly mon­key­pox pro­gram un­der­way

As Mod­er­na pre­pares two bi­va­lent vari­ant-spe­cif­ic Covid-19 boost­ers for de­liv­ery in the fall and looks in­to a po­ten­tial mon­key­pox pro­gram, CEO Stéphane Ban­cel stressed on the Q2 call that “now is not the time to slow down.”

The com­pa­ny’s stock $MR­NA soared more than 15% Wednes­day morn­ing, af­ter Ban­cel re­port­ed a strong quar­ter and a new $3 bil­lion share buy­back plan. Covid sales took a dip com­pared to last quar­ter, com­ing in at $4.5 bil­lion as op­posed to $5.9 bil­lion in Q1.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER